Prevention of local symptoms in muscle invasive bladder cancer patients: clinical significance of local radiation therapy-Reference-Cited by-同舟云学术

Prevention of local symptoms in muscle invasive bladder cancer patients: clinical significance of local radiation therapy

Published:2023-10 Issue:10 Volume:31 Page:
ISSN:0941-4355
Container-title:Supportive Care in Cancer
language:en
Short-container-title:Support Care Cancer

Author:

Okada Manabu,Shindo Tetsuya,Fujino Keiko,Maeda Toshihiro,Ito Naoki,Takahashi Atsushi,Hotta Hiroshi,Kunishima Yasuharu,Matsukawa Masanori,Takayanagi Akio,Wanifuchi Atsushi,Nofuji Seisuke,Kato Ryuichi,Fukuta Fumimasa,Hashimoto Kohei,Kobayashi Ko,Tanaka Toshiaki,Masumori Naoya

Publisher

Springer Science and Business Media LLC

Subject

Oncology

Link

https://link.springer.com/content/pdf/10.1007/s00520-023-08087-6.pdf

Reference32 articles.

1. Siegel RL, Miller KD, Jemal A (2020) Cancer statistics, 2020. CA Cancer J Clin 70:7–30

2. Kamat AM, Hahn NM, Efstathiou JA, Lerner SP, Malmstrom PU, Choi W, Guo CC, Lotan Y, Kassouf W (2016) Bladder cancer. Lancet 388:2796–2810

3. Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data advanced bladder cancer (ABC) meta-analysis collaboration, (2005) Eur Urol 48: 202 205; discussion 205–206

4. Kitamura H, Tsukamoto T, Shibata T, Masumori N, Fujimoto H, Hirao Y, Fujimoto K, Kitamura Y, Tomita Y, Tobisu K, Niwakawa M, Naito S, Eto M, Kakehi Y, Urologic Oncology Study Group of the Japan Clinical Oncology, G (2014) Randomised phase III study of neoadjuvant chemotherapy with methotrexate, doxorubicin, vinblastine and cisplatin followed by radical cystectomy compared with radical cystectomy alone for muscle-invasive bladder cancer: Japan Clinical Oncology Group Study JCOG0209. Ann Oncol 25:1192–1198

5. Raphael MJ, Booth CM (2019) Neoadjuvant chemotherapy for muscle-invasive bladder cancer: underused across the 49(th) parallel. Can Urol Assoc J 13:29–31